CYP1A2

細胞色素P450 1A2（英語：Cytochrome P450 1A2） （縮寫為CYP1A2），是細胞色素P450混合功能氧化酶家族的一員，參與體內異生物質的代謝。CYP1A2酶由人類CYP1A2基因編碼。

Cytochrome P450, family 1, subfamily A, polypeptide 2
PDB根據2hi4所繪製的渲染圖
有效結構 PDB 直系同源檢索：PDBe, RCSB PDB查詢代碼列表 2HI4
標識
代號	CYP1A2; CP12; P3-450; P450(PA)
擴展標識	遺傳學：124060 鼠基因：88589 同源基因：68082 ChEMBL: 3356 GeneCards: CYP1A2 Gene
EC編號	1.14.14.1
基因本體論描述 分子功能 · monooxygenase activity · iron ion binding · electron carrier activity · oxidoreductase activity · oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen · enzyme binding · heme binding · demethylase activity · caffeine oxidase activity · aromatase activity 細胞成分 · endoplasmic reticulum membrane · intracellular membrane-bounded organelle 生物過程 · steroid catabolic process · porphyrin-containing compound metabolic process · xenobiotic metabolic process · toxin biosynthetic process · post-embryonic development · alkaloid metabolic process · regulation of gene expression · monoterpenoid metabolic process · drug metabolic process · dibenzo-p-dioxin metabolic process · arachidonic acid metabolic process · epoxygenase P450 pathway · lung development · methylation · response to estradiol · response to lipopolysaccharide · monocarboxylic acid metabolic process · response to immobilization stress · drug catabolic process · exogenous drug catabolic process · small molecule metabolic process · cellular respiration · heterocycle metabolic process · hydrogen peroxide biosynthetic process · oxidation-reduction process · oxidative demethylation · cellular response to cadmium ion · oxidative deethylation · omega-hydroxylase P450 pathway Sources: Amigo / QuickGO
RNA表達模式
更多表達數據
直系同源體
物種	人類	小鼠
Entrez	1544	13077
Ensembl	ENSG00000140505	ENSMUSG00000032310
UniProt	P05177	P00186
mRNA序列	NM_000761	NM_009993
蛋白序列	NP_000752	NP_034123
基因位置	Chr 15: 74.75 – 74.76 Mb	Chr 9: 57.68 – 57.68 Mb
PubMed查詢	[1]	[2]

延伸閱讀

• Meijerman I, Beijnen J, Schellens J. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist. 2006, 11 (7): 742–52. PMID 16880233. doi:10.1634/theoncologist.11-7-742. 
• Smith G, Stubbins MJ, Harries LW, Wolf CR. Molecular genetics of the human cytochrome P450 monooxygenase superfamily.. Xenobiotica. 1999, 28 (12): 1129–65. PMID 9890157. doi:10.1080/004982598238868. 
• Landi MT, Sinha R, Lang NP, Kadlubar FF. Human cytochrome P4501A2.. IARC Sci. Publ. 1999, (148): 173–95. PMID 10493258. 
• Ikeya K, Jaiswal AK, Owens RA; et al. Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression.. Mol. Endocrinol. 1990, 3 (9): 1399–408. PMID 2575218. doi:10.1210/mend-3-9-1399. 
• Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.. Proc. Natl. Acad. Sci. U.S.A. 1989, 86 (20): 7696–700. PMC 298137 . PMID 2813353. doi:10.1073/pnas.86.20.7696. 
• Quattrochi LC, Okino ST, Pendurthi UR, Tukey RH. Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.. DNA. 1986, 4 (5): 395–400. PMID 3000715. doi:10.1089/dna.1985.4.395. 
• Quattrochi LC, Pendurthi UR, Okino ST; et al. Human cytochrome P-450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA.. Proc. Natl. Acad. Sci. U.S.A. 1986, 83 (18): 6731–5. PMC 386583 . PMID 3462722. doi:10.1073/pnas.83.18.6731. 
• Wrighton SA, Campanile C, Thomas PE; et al. Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat.. Mol. Pharmacol. 1986, 29 (4): 405–10. PMID 3517618. 
• Jaiswal AK, Nebert DW, Gonzalez FJ. Human P3(450): cDNA and complete amino acid sequence.. Nucleic Acids Res. 1986, 14 (16): 6773–4. PMC 311685 . PMID 3755823. doi:10.1093/nar/14.16.6773. 
• Eugster HP, Probst M, Würgler FE, Sengstag C. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.. Drug Metab. Dispos. 1993, 21 (1): 43–9. PMID 8095225. 
• Schweikl H, Taylor JA, Kitareewan S; et al. Expression of CYP1A1 and CYP1A2 genes in human liver.. Pharmacogenetics. 1994, 3 (5): 239–49. PMID 8287062. doi:10.1097/00008571-199310000-00003. 
• Yamazaki H, Inoue K, Mimura M; et al. 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes.. Biochem. Pharmacol. 1996, 51 (3): 313–9. PMID 8573198. doi:10.1016/0006-2952(95)02178-7. 
• Hakkola J, Raunio H, Purkunen R; et al. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy.. Biochem. Pharmacol. 1996, 52 (2): 379–83. PMID 8694864. doi:10.1016/0006-2952(96)00216-X. 
• Guengerich FP, Johnson WW. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.. Biochemistry. 1998, 36 (48): 14741–50. PMID 9398194. doi:10.1021/bi9719399. 
• Wacke R, Kirchner A, Prall F; et al. Up-regulation of cytochrome P450 1A2, 2C9, and 2E1 in chronic pancreatitis.. Pancreas. 1998, 16 (4): 521–8. PMID 9598815. doi:10.1097/00006676-199805000-00011. 
• Macé K, Bowman ED, Vautravers P; et al. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues.. Eur. J. Cancer. 1998, 34 (6): 914–20. PMID 9797707. doi:10.1016/S0959-8049(98)00034-3. 
• Huang JD, Guo WC, Lai MD; et al. Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese.. Drug Metab. Dispos. 1999, 27 (1): 98–101. PMID 9884316. 
• Tatemichi M, Nomura S, Ogura T; et al. Mutagenic activation of environmental carcinogens by microsomes of gastric mucosa with intestinal metaplasia.. Cancer Res. 1999, 59 (16): 3893–8. PMID 10463577.